Vanderbilt researchers propose guidelines for defining patient retention in clinical studies – an important parameter that affects study conclusions and program evaluations.

Genetic testing has revolutionized the treatment of patients with HIV/AIDS. But it is not a panacea.

Researchers at the Vanderbilt Institute for Global Health (VIGH) have received a major federal grant to study whether an integrated, family-focused approach can prevent mother-to-child transmission of HIV — the AIDS virus — in Nigeria.

Vanderbilt University has received a major federal grant — just more than $7 million in the first year — to extend HIV/AIDS-related technical assistance and training in the rural province of Zambézia, Mozambique.

The protein APOBEC3G contributes to spontaneous control of HIV-1 in vivo and may provide therapeutic benefits.

Vanderbilt University’s Vikrant Sahasrabuddhe, M.D., MPH, DrPH, received the IAS/ANRS Young Investigator Award at the International AIDS Conference last week in Washington, D.C.

Anti-retroviral therapy can prevent tuberculosis, even in people with early HIV disease.